IVERIC bio, Inc.(NASDAQ : ISEE)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||-7.57%||6.47||0.7%||$452.28m|
|GILD||Gilead Sciences, Inc.||-0.76%||67.63||1.0%||$426.45m|
|REGN||Regeneron Pharmaceuticals, Inc.||-0.43%||553.24||2.7%||$408.99m|
|XLRN||Acceleron Pharma, Inc.||0.50%||172.94||5.3%||$345.45m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.07%||181.77||1.9%||$259.59m|
|XENE||Xenon Pharmaceuticals, Inc.||2.12%||33.66||0.4%||$178.19m|
|JSPR||Jasper Therapeutics, Inc.||31.57%||16.42||0.0%||$158.53m|
IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in New York, NY.